Gabelli Funds LLC Has $48,283,000 Holdings in UnitedHealth Group Incorporated (UNH)
Gabelli Funds LLC maintained its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 260,400 shares of the healthcare conglomerate’s stock at the end of the second quarter. Gabelli Funds LLC’s holdings in UnitedHealth Group were worth $48,283,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors also recently added to or reduced their stakes in UNH. Patriot Financial Group Insurance Agency LLC raised its stake in UnitedHealth Group by 1,722.9% during the first quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock worth $106,000 after acquiring an additional 603 shares in the last quarter. Kings Point Capital Management raised its stake in UnitedHealth Group by 27.9% during the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock worth $113,000 after acquiring an additional 150 shares in the last quarter. Founders Capital Management acquired a new position in UnitedHealth Group during the first quarter worth $135,000. Parkside Financial Bank & Trust raised its stake in UnitedHealth Group by 1.4% during the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock worth $140,000 after acquiring an additional 12 shares in the last quarter. Finally, Hanson McClain Inc. raised its stake in UnitedHealth Group by 1.7% during the first quarter. Hanson McClain Inc. now owns 895 shares of the healthcare conglomerate’s stock worth $147,000 after acquiring an additional 15 shares in the last quarter. Hedge funds and other institutional investors own 86.11% of the company’s stock.
UnitedHealth Group Incorporated (UNH) opened at 205.23 on Thursday. UnitedHealth Group Incorporated has a one year low of $133.03 and a one year high of $207.80. The company has a market cap of $198.43 billion, a PE ratio of 24.66 and a beta of 0.63. The firm’s 50-day moving average price is $196.96 and its 200-day moving average price is $185.50.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, beating analysts’ consensus estimates of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The firm had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. During the same quarter in the previous year, the company posted $2.17 EPS. The business’s revenue was up 8.7% on a year-over-year basis. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post $9.91 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th were given a $0.75 dividend. The ex-dividend date of this dividend was Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.46%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.13%.
UNH has been the subject of several recent analyst reports. Cantor Fitzgerald reiterated an “overweight” rating and set a $208.00 price objective on shares of UnitedHealth Group in a research note on Friday, July 21st. ValuEngine upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Oppenheimer Holdings, Inc. reiterated an “outperform” rating and set a $205.00 price objective (up from $203.00) on shares of UnitedHealth Group in a research note on Friday, July 21st. Finally, BidaskClub lowered UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 19th. Three investment analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the company. The stock currently has a consensus rating of “Buy” and an average price target of $212.40.
In other UnitedHealth Group news, insider Larry C. Renfro sold 50,574 shares of the company’s stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $198.11, for a total value of $10,019,215.14. Following the sale, the insider now owns 195,625 shares in the company, valued at approximately $38,755,268.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total value of $969,900.00. Following the completion of the sale, the director now owns 76,058 shares in the company, valued at approximately $14,753,730.84. The disclosure for this sale can be found here. Insiders sold a total of 76,174 shares of company stock worth $14,981,909 in the last quarter. Corporate insiders own 0.89% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.